Patents by Inventor Stephen D. Dertinger

Stephen D. Dertinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070274919
    Abstract: The present invention relates a method for the enumeration of in vivo gene mutation. The method utilizes differential staining of GPI-anchor deficient erythrocyte populations to distinguish between wild-type and pig-a gene mutants. Quantitative analyses can be conducted on erythrocytes and/or reticulocytes, and is based upon fluorescent emission and light scatter following exposure to an excitatory light source. Counting of mutant erythrocytes or reticulcoytes relative to the number of total erythrocytes or reticulocytes can be used to assess the DNA-damaging potential of an exogenous chemical agent, the DNA-damaging potential of an exogenous physical agent, the effects of an exogenous agent which can modify endogenously-induced DNA damage, and the effects of an exogenous agent which can modify exogenously-induced DNA damage. Kits for practicing the invention are also disclosed.
    Type: Application
    Filed: May 23, 2007
    Publication date: November 29, 2007
    Applicant: LITRON LABORATORIES, LTD.
    Inventor: Stephen D. Dertinger
  • Publication number: 20030134305
    Abstract: A single-laser flow cytometric method for the enumeration of micronucleated erythrocyte populations is disclosed which affords superior fluorescent resolution of young reticulocytes from normochromatic erythrocytes, particularly in mammals that exhibit efficient splenic sequestering.
    Type: Application
    Filed: August 16, 2002
    Publication date: July 17, 2003
    Inventors: Stephen D. Dertinger, Dorothea K. Torous, Carol R. Tometsko
  • Patent number: 6100038
    Abstract: A single laser flow cytometric method for the enumeration of micronuclei in erythrocyte populations, wherein a sample of peripheral blood or bone marrow is obtained and the cell populations in the sample are fixed. Reticulocytes in the fixed samples are treated simultaneously with RNAse and with a fluorescent labeled antibody having binding specificity for a surface marker for erythroblasts/reticulocytes. The erythrocyte populations are then stained with a nucleic acid stain which stains DNA representing micronuclei, if present. The stained and/or labeled erythrocyte populations are then exposed to a laser beam of appropriate excitation wavelength for both the nucleic acid staining dye and the fluorescent label to produce fluorescent emission. The fluorescent emission and light scatter produced by the erythrocyte populations are detected by the flow cytometer from which is calculated the number of specific erythrocyte populations in said sample.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: August 8, 2000
    Assignee: Litron Laboratories Limited
    Inventors: Stephen D. Dertinger, Dorothea K. Torous, Kenneth R. Tometsko